共 147 条
[1]
Paez JG(2004)EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497-1500
[2]
Janne PA(2006)The role of gefitinib treatment for Korean never-smokers with advanced or metastatic adenocarcinoma of the lung: a prospective study J Thorac Oncol 1 965-971
[3]
Lee JC(2008)Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403) Br J Cancer 98 907-914
[4]
Lee DH(2005)Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy Cell Res 15 212-217
[5]
Han JY(2004)EGF receptor mutations are common in lung cancers from “never-smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 13306-13311
[6]
Yu SY(2008)Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers Gen Thorac Cardiovasc Surg 56 97-103
[7]
Tamura K(2004)EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497-1500
[8]
Okamoto I(2007)Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer Cancer Sci 98 1817-1824
[9]
Kashii T(2005)EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment J Clin Oncol 23 857-865
[10]
Qin BM(2004)High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan Clin Cancer Res 10 8195-8203